CELLDEX THERAPEUTICS INC NEW's ticker is CLDX and the CUSIP is 15117B202. A total of 161 filers reported holding CELLDEX THERAPEUTICS INC NEW in Q1 2023. The put-call ratio across all filers is 0.51 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,021,955 | +4.2% | 37,135 | +28.5% | 0.00% | – |
| Q2 2023 | $980,916 | -71.3% | 28,910 | -69.6% | 0.00% | -100.0% |
| Q1 2023 | $3,423,713 | +0.4% | 95,156 | +24.4% | 0.00% | 0.0% |
| Q4 2022 | $3,408,803 | +614.6% | 76,482 | +350.5% | 0.00% | – |
| Q3 2022 | $477,000 | -11.5% | 16,977 | -15.0% | 0.00% | – |
| Q2 2022 | $539,000 | -12.5% | 19,974 | +10.2% | 0.00% | – |
| Q1 2022 | $616,000 | -92.3% | 18,123 | -91.3% | 0.00% | -100.0% |
| Q4 2021 | $8,025,000 | -72.2% | 207,672 | -61.1% | 0.00% | -71.4% |
| Q3 2021 | $28,830,000 | +100.3% | 533,985 | +24.1% | 0.01% | +75.0% |
| Q2 2021 | $14,392,000 | +168.2% | 430,407 | +65.2% | 0.00% | +300.0% |
| Q1 2021 | $5,366,000 | -32.3% | 260,495 | -51.3% | 0.00% | -66.7% |
| Q3 2020 | $7,928,000 | +8909.1% | 534,584 | +1257.0% | 0.00% | – |
| Q4 2019 | $88,000 | -1.1% | 39,394 | -6.2% | 0.00% | – |
| Q3 2019 | $89,000 | -23.9% | 41,997 | -3.8% | 0.00% | – |
| Q2 2019 | $117,000 | -47.3% | 43,641 | -3.3% | 0.00% | – |
| Q1 2019 | $222,000 | – | 45,148 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Kynam Capital Management, LP | 3,200,000 | $88,064,000 | 14.40% |
| Octagon Capital Advisors LP | 759,898 | $20,912,393 | 3.21% |
| TSP Capital Management Group, LLC | 251,695 | $6,926,645 | 2.67% |
| 5AM Venture Management, LLC | 310,270 | $8,538,630 | 2.46% |
| COMMODORE CAPITAL LP | 706,665 | $19,447,421 | 2.27% |
| ACUTA CAPITAL PARTNERS, LLC | 122,341 | $3,366,824 | 2.26% |
| Redmile Group, LLC | 1,635,938 | $45,021,014 | 2.14% |
| RTW INVESTMENTS, LP | 3,463,201 | $95,307,292 | 2.01% |
| Eversept Partners, LP | 588,143 | $16,185,695 | 1.37% |
| Affinity Asset Advisors, LLC | 150,000 | $4,128,000 | 1.16% |